Clinical Trial Update: Pramlintide Combined With Model Predictive Control Algorithm [NA]

View source ↗

Summary

This update reports the termination of a clinical trial evaluating pramlintide combined with a model predictive control algorithm for Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• pramlintide (pramlintide)

Snippet

Sponsor: University of Virginia | Conditions: Type 1 Diabetes Mellitus | NA | Status: TERMINATED